Imidazenil: A potent and safe protective agent against diisopropyl fluorophosphate toxicity

Neuropharmacology

Volumn 46, Issue 3, 2004, Pages 397-403

  Auta, James ^a   Costa, Erminio ^a   Davis, John ^a   Guidotti, Alessandro ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cholinergic receptors; Diisopropyl fluorophosphate (DFP); GABA receptors; Imidazenil; Neurotoxicity

Indexed keywords

ANTICONVULSIVE AGENT; ATROPINE; DIAZEPAM; DYFLOS; IMIDAZENIL;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; MALE; MORTALITY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; SEDATION;

EID: 1242306547     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2003.09.010     Document Type: Article

References (29)

1. Auta J., Giusti P., Guidotti A., Costa E. Imidazenil, a partial positive allosteric modulator of GABAA receptors, exhibit low tolerance and dependence liabilities in rat. Journal of Pharmacology and Experimental Therapeutics. 270:1994;1262-1269.
2. A receptor complex on behavioral processes in monkeys. Behavioral Pharmacology. 6:1995;323-332.
3. Auta J., Guidotti A., Costa E. Imidazenil prevention of Alprazolam-induced acquisition deficit in patas monkeys is devoid of tolerance. Proceedings of the National Academy of Science USA 97. 2000;2314-2319.
4. Churchill L., Pazdernik T.L., Jackson J.L., Nelson S.R., Samson F.E., McDonough J.H., McLeod C.G. Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography. Neurotoxicology. 6:1985;81-90.
5. A receptors. Mohler H. Handbook of Experimental Pharmacology. vol. 150:2001;227-250 Springer Verlag, Berlin.
6. A receptors and benzodiazepines: a role for dendritic resident subunit mRNAs. Neuropharmacology. 43:2002;925-937.
7. Dawson R.M. Review of oximes available for treatment of nerve agent poisoning. Journal of Applied Toxicology. 14:1994;317-331.
8. De Candole C.A., Douglas W.W., Lovatt-Evans C., Holmes R., Spencer K.E.V., Torrance R.W., Wilson K.M. The failure of respiration in death by anticholinesterase poisoning. British Journal of Pharmacology and Chemotherapy. 8:1953;466-475.
9. Gillis R.A., Namath I.J., Easington C., Abrahams T.P., Guidotti A., Quest J.A., Hamosh P., Taveira da Silva A.M. Drug interaction with gamma-aminobutyric acid/benzodiazepine in the ventral surface of the medulla results in pronounced change in cardiovascular activity. Journal of Pharmacology and Experimental Therapeutics. 248:(2):1989;963-970.
10. A receptors. Journal of Pharmacology and Experimental Therapeutics. 266:1993;1018-1028.
11. Greenblatt D.J., Shader R.I. Dependence, tolerance and addiction to benzodiazepines: clinical and pharmacological considerations. Drug Metabolism Review. 8:1978;13-28.
12. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. Journal of Neurological Sciences. 98:1990;99-106.
13. Leikin J.B., Thomas R.G., Walter F.G., Klein R., Meislin H.W. A review of nerve agent exposure for the critical care physician. Critical Care Medicine. 10:2002;2346-2354.
14. Lipp J.A. Effect of diazepam upon soman-induced seizure activity and convulsions. Electroencephalography and Clinical Neurophysiology. 32:1972;557-560.
15. Lipp J.A. Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Archives Internationales de pharmacodynamie et de therapie. 2002:1973;244-251.
16. Lipp J., Dola T. Comparison of the efficacy of HS-6 versus HI-6 when combined with atropine, pyridostigmine, and clonazepam for soman poisoning in the monkey. Archives Internationales de pharmacodynamie et de therapie. 246:(1):1980;138-148.
17. Martin L.J., Doebler J.A., Shih T.M., Anthony A. Protective effect of diazepam pretreatment on soman-induced brain lesion formation. Brain Research. 325:1985;287-289.
18. McDonough J.H., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundamental and Applied Toxicology. 13:1989;256-276.
19. McDonough J.H., McLeod C.G., Nipwoda M.T. Direct microinjection of or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Research. 435:1987;123-137.
20. McDonough J.H. Jr., Shih T.M. Pharmacological modulation of soman-induced seizures. Neuroscience and Behavioral Reviews. 17:1993;203-215.
21. McLeod C.G., Singer W., Harrington D.G. Acute neuropathology in soman poisoned rats. Fundamental and Applied Toxicology. 5:1984;53-58.
22. Petras J.M. Soman neurotoxicity. Fundamental and Applied Toxicology. 1:1982;73-83.
23. Philippens I.H.C.H.M., Melchers B.P.C., DeGroot D.M.G., Wolthius O.L. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rast. Pharmacology, Biochemistry and Behavior. 42:1992;711-719.
24. Rickett D.L., Glenn J.F., Beers E.T. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology. 7:1986;225-236.
25. Shih T.M. Anticonvulsant effect of diazepam and MK-801 in soman poisoning. Epilepsy Research. 7:1990;105-116.
26. Solberg Y., Belkin M. The role of excitotoxicity in organophosphorous nerve agents central poisoning. Trends in Pharmacological Sciences. 18:1997;183-185.
27. Taylor P. Anticholinesterase agents. Hardman J.G., Limbird L.E. The Pharmacological Basis of Therapeutics. third ed. 1996;161-176 McGraw Hill, New York.
28. Thompson D.M., Auta J., Guidotti A., Costa E. Imidazenil, a new anxiolytic and anticonvulsant drug attenuates a benzodiazepine-induced cognition deficit in monkeys. Journal of Pharmacology and Experimental Therapeutics. 273:1995;1307-1312.
29. Tonduli L.S., Testylier G., Masqueliez C., Lallement G., Monmaur P. Effects of Huperzine used as pretreatment against soman-induced seizures. Neurotoxicology. 22:(1):2001;29-37.